Signify Bio is a biotechnology company harnessing the human body for the production of in situ protein therapeutics.
Signify Bio has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Signify Bio's investors include Eli Lilly, Danaher Ventures, BrightEdge - American Cancer Society, Actium Group, Strategic Investment Fund.
Signify Bio is headquartered in Dallas, United States.
Signify Bio is a biotechnology company harnessing the human body for the production of in situ protein therapeutics.
Signify Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Signify Bio — Funding & Investors." VCBacked, June 5, 2025, https://www.vcbacked.co/company/signify-bio. Accessed July 30, 2026.
VCBacked. (2025). Signify Bio — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/signify-bio
{{cite web |title=Signify Bio — Funding & Investors |url=https://www.vcbacked.co/company/signify-bio |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated